Stocks to buy

The coronavirus pandemic disrupted many businesses and was a boon to others. One sector that’s been riding high is the pharmaceutical industry. That’s especially true for companies that have brought a Covid-19 vaccine to market. Vaccine developer Novavax (NASDAQ:NVAX) is a perfect example. NVAX stock rose from relative obscurity with a share price of just
0 Comments
Nvidia’s (NASDAQ:NVDA) core businesses have been firing on all cylinders, and its move into other profitable verticals has resulted in consistent top-line growth.  The company’s market value has grown at an incredible pace over the past decade. Yet, NVDA stock still has a ton of upside left with new catalysts that will amplify growth in
0 Comments
Biotech stocks are infamously one of the most volatile sectors in the stock market. Investors often venture into speculative companies with no proven pipelines. Emerging firms with a pipeline of drugs and products still in the clinical phase post little to no revenue. They raise cash by tapping capital markets to pay for research and
0 Comments
Last year, a paradigm shift occurred — and I’m not just talking about the novel coronavirus. Certainly, the global health crisis initially devastated economies the world over, and we’re still working through the rubble. But amid the mess, a new wave of investors jumped onto trading platforms like Robinhood (NASDAQ:HOOD), driving up broader market sentiment.
0 Comments
AT&T (NYSE:T) is undergoing some structural changes, which have investors concerned about its future prospects. However, the company should emerge as a more streamlined and robust enterprise after its successful reorganization. It’s positioned incredibly well to benefit from the 5G boom, and its decision to focus on its core business has already started to pay
0 Comments